Tamara S. Hannon

Tamara S. Hannon

Auto-generated profile, based on publicly available information

Tamara S. Hannon

Indiana University School of Medicine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MRMichael R. Rickels
Michael R. Rickels
CECarmella Evans-Molina
Carmella Evans-Molina
HBHenry T. Bahnson
Henry T. Bahnson
AYAlyssa Ylescupidez
Alyssa Ylescupidez
KNKristen J. Nadeau
Kristen J. Nadeau
CGCarla J. Greenbaum
Carla J. Greenbaum
BACKGROUND. Residual C-peptide is detected in many people for years following the diagnosis of type 1 diabetes; however, the physiologic significance of low levels of detectable C-peptide is not known. METHODS. We studied 63 adults with type 1 diabetes classified by peak mixed-meal tolerance test (MMTT) C-peptide as negative (0.200–0.400; n = 15), or high (>0.400; n = 17). We compared the groups’ glycemia from continuous glucose monitoring (CGM), β cell secretory responses from a glucose-potentiated arginine (GPA) test, insulin sensitivity from a hyperinsulinemic-euglycemic (EU) clamp, and glucose counterregulatory responses from a subsequent hypoglycemic (HYPO) clamp. RESULTS. Low and intermediate MMTT C-peptide groups did not exhibit β cell secretory responses to hyperglycemia, whereas the high C-peptide group showed increases in both C-peptide and proinsulin (P ≤ 0.01). All groups with detectable MMTT C-peptide demonstrated acute C-peptide and proinsulin responses to arginine that were positively correlated with peak MMTT C-peptide (P < 0.0001 for both analytes). During the EU-HYPO clamp, C-peptide levels were proportionately suppressed in the low, intermediate, and high C-peptide compared with the negative group (P ≤ 0.0001), whereas glucagon increased from EU to HYPO only in the high C-peptide group compared with negative (P = 0.01). CGM demonstrated lower mean glucose and more time in range for the high C-peptide group. CONCLUSION. These results indicate that in adults with type 1 diabetes, β cell responsiveness to hyperglycemia and α cell responsiveness to hypoglycemia are observed only at high levels of residual C-peptide that likely contribute to glycemic control. FUNDING. Funding for this work was provided by the Leona M. and Harry B. Helmsley Charitable Trust, the National Center for Advancing Translational Sciences, and the National Institute of Diabetes and Digestive and Kidney Diseases.

11 May 2017 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
THTamara S. Hannon
Tamara S. Hannon
SKSteven E. Kahn
Steven E. Kahn
KUKristina M. Utzschneider
Kristina M. Utzschneider
TBThomas A. Buchanan
Thomas A. Buchanan
KNKristen J. Nadeau
Kristen J. Nadeau
FCfor the RISE Consortium
for the RISE Consortium

17 September 2025 in The Lancet
Verified
Journal Article
Closed access
THTamara S Hannon
Tamara S Hannon
LCLily C Chao
Lily C Chao
MBMargarita Barrientos-Pérez
Margarita Barrientos-Pérez
KPKarthik Chandrasekhar Pamidipati
Karthik Chandrasekhar Pamidipati
LLLaura Fernández Landó
Laura Fernández Landó
BBBrandon K Bergman
Brandon K Bergman

16 June 2018 in Current Diabetes Reports
Verified
Journal Article
Closed access
PDF file
MCMelinda E. Chen
Melinda E. Chen
RARebecca S. Aguirre
Rebecca S. Aguirre
THTamara S. Hannon
Tamara S. Hannon

24 February 2021 in Journal of Participatory Medicine
Verified
Journal Article
Open access
JPJulie M Pike
Julie M Pike
CMCourtney M Moore
Courtney M Moore
LYLisa G Yazel
Lisa G Yazel
DLDustin O Lynch
Dustin O Lynch
KHKathryn M Haberlin-Pittz
Kathryn M Haberlin-Pittz
THTamara S Hannon
Tamara S Hannon
Background: The rise in pediatric obesity and its accompanying condition, type 2 diabetes (T2D), is a serious public health concern. T2D in adolescents is associated with poor health outcomes and decreased life expectancy. Effective diabetes prevention strategies for high-risk adolescents and their families are urgently needed. Objective: The aim of this study was to co-design a diabetes prevention program for adolescents by using human-centered design methodologies. Methods: We partnered with at-risk adolescents, parents, and professionals with expertise in diabetes prevention or those working with adolescents to conduct a series of human-centered design research sessions to co-design a diabetes prevention intervention for youth and their families. In order to do so, we needed to (1) better understand environmental factors that inhibit/promote recommended lifestyle changes to decrease T2D risk, (2) elucidate desired program characteristics, and (3) explore improved activation in diabetes prevention programs. Results: Financial resources, limited access to healthy foods, safe places for physical activity, and competing priorities pose barriers to adopting lifestyle changes. Adolescents and their parents desire interactive, hands-on learning experiences that incorporate a sense of fun, play, and community in diabetes prevention programs. Conclusions: The findings of this study highlight important insights of 3 specific stakeholder groups regarding diabetes prevention and lifestyle changes. The findings of this study demonstrate that, with appropriate methods and facilitation, adolescents, parents, and professionals can be empowered to co-design diabetes prevention programs.
1

10 May 2018 in Journal of Participatory Medicine
Verified
Journal Article
Open access
THTamara S Hannon
Tamara S Hannon
CMCourtney M Moore
Courtney M Moore
ECErika R. Cheng
Erika R. Cheng
DLDustin O Lynch
Dustin O Lynch
LYLisa G Yazel-Smith
Lisa G Yazel-Smith
SWSarah E Wiehe
Sarah E Wiehe
Adolescents with type 1 diabetes mellitus have difficulty achieving optimal glycemic control, partly due to competing priorities that interfere with diabetes self-care. Often, significant diabetes-related family conflict occurs, and adolescents’ thoughts and feelings about diabetes management may be disregarded. Patient-centered diabetes outcomes may be better when adolescents feel engaged in the decision-making process. The objective of our study was to codesign a clinic intervention using shared decision making for addressing diabetes self-care with an adolescent patient and parent advisory board. The patient and parent advisory board consisted of 6 adolescents (teens) between the ages 12 and 18 years with type 1 diabetes mellitus and their parents recruited through our institution’s Pediatric Diabetes Program. Teens and parents provided informed consent and participated in 1 or both of 2 patient and parent advisory board sessions, lasting 3 to 4 hours each. Session 1 topics were (1) patient-centered outcomes related to quality of life, parent-teen shared diabetes management, and shared family experiences; and (2) implementation and acceptability of a patient-centered diabetes care plan intervention where shared decision making was used. We analyzed audio recordings, notes, and other materials to identify and extract ideas relevant to the development of a patient-centered diabetes management plan. These data were visually coded into similar themes. We used the information to develop a prototype for a diabetes management plan tool that we pilot tested during session 2. Session 1 identified 6 principal patient-centered quality-of-life measurement domains: stress, fear and worry, mealtime struggles, assumptions and judgments, feeling abnormal, and conflict. We determined 2 objectives to be principally important for a diabetes management plan intervention: (1) focusing the intervention on diabetes distress and conflict resolution strategies, and (2) working toward a verbalized common goal. In session 2, we created the diabetes management plan tool according to these findings and will use it in a clinical trial with the aim of assisting with patient-centered goal setting. Patients with type 1 diabetes mellitus can be effectively engaged and involved in patient-centered research design. Teens with type 1 diabetes mellitus prioritize reducing family conflict and fitting into their social milieu over health outcomes at this time in their lives. It is important to acknowledge this when designing interventions to improve health outcomes in teens with type 1 diabetes mellitus.